Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$1.39 - $2.21 $215,588 - $342,771
-155,100 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$1.5 - $9.38 $31,500 - $196,980
21,000 Added 15.66%
155,100 $279,000
Q2 2020

Aug 12, 2020

BUY
$4.79 - $8.39 $49,816 - $87,256
10,400 Added 8.41%
134,100 $1.13 Million
Q1 2020

May 12, 2020

BUY
$3.44 - $7.21 $89,784 - $188,181
26,100 Added 26.74%
123,700 $648,000
Q4 2019

Jan 27, 2020

BUY
$4.29 - $5.64 $295,683 - $388,731
68,924 Added 240.35%
97,600 $533,000
Q3 2019

Oct 31, 2019

BUY
$4.87 - $7.08 $40,274 - $58,551
8,270 Added 40.53%
28,676 $140,000
Q2 2019

Aug 15, 2019

SELL
$6.6 - $7.8 $138,956 - $164,221
-21,054 Reduced 50.78%
20,406 $141,000
Q1 2019

May 03, 2019

BUY
$5.76 - $8.95 $238,809 - $371,066
41,460 New
41,460 $288,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $691M
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.